共 50 条
- [23] Difluprednate ophthalmic emulsion 0.05% (Durezol (R)) administered two times daily for managing ocular inflammation and pain following cataract surgery CLINICAL OPHTHALMOLOGY, 2010, 4 : 983 - 991
- [24] Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial CLINICAL OPHTHALMOLOGY, 2012, 6 : 1113 - 1124
- [25] Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability Advances in Therapy, 2022, 39 : 5474 - 5486
- [27] Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery (vol 33, pg 53, 2007) JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (04): : 564 - 564
- [29] Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2013, 39 (02): : 168 - 173
- [30] Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2019, 45 (02): : 204 - 212